These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 34607932

  • 21. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways.
    Lim L, Manser E, Leung T, Hall C.
    Eur J Biochem; 1996 Dec 01; 242(2):171-85. PubMed ID: 8973630
    [Abstract] [Full Text] [Related]

  • 22. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J, Halstead-Nussloch G, Ito K, Katsyv I, Irie HY.
    Breast Cancer Res; 2016 Sep 23; 18(1):95. PubMed ID: 27663795
    [Abstract] [Full Text] [Related]

  • 23. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC, Huang Y, Woodcock SR, Salvatore SR, Singh B, Golin-Bisello F, Davidson NE, Neumann CA, Freeman BA, Wendell SG.
    J Biol Chem; 2018 Jan 26; 293(4):1120-1137. PubMed ID: 29158255
    [Abstract] [Full Text] [Related]

  • 24. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.
    Zhang Y, Rivera Rosado LA, Moon SY, Zhang B.
    J Biol Chem; 2009 May 08; 284(19):12956-65. PubMed ID: 19269969
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Panitumumab-DOTA-111In: An Epidermal Growth Factor Receptor Targeted Theranostic for SPECT/CT Imaging and Meitner-Auger Electron Radioimmunotherapy of Triple-Negative Breast Cancer.
    Facca VJ, Cai Z, Gopal NEK, Reilly RM.
    Mol Pharm; 2022 Oct 03; 19(10):3652-3663. PubMed ID: 35926098
    [Abstract] [Full Text] [Related]

  • 27. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
    Chang CH, Bijian K, Wernic D, Su J, da Silva SD, Yu H, Qiu D, Asslan M, Alaoui-Jamali MA.
    Autophagy; 2019 Aug 03; 15(8):1376-1390. PubMed ID: 30773992
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
    Thies KA, Cole MW, Schafer RE, Spehar JM, Richardson DS, Steck SA, Das M, Lian AW, Ray A, Shakya R, Knoblaugh SE, Timmers CD, Ostrowski MC, Chakravarti A, Sizemore GM, Sizemore ST.
    Breast Cancer Res; 2021 Jun 12; 23(1):65. PubMed ID: 34118960
    [Abstract] [Full Text] [Related]

  • 31. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H, Wu T, Xie D, Li D, Hua K, Hu J, Fang L.
    Cell Physiol Biochem; 2018 Jun 12; 48(5):1968-1982. PubMed ID: 30092563
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer.
    Rosenblatt AE, Garcia MI, Lyons L, Xie Y, Maiorino C, Désiré L, Slingerland J, Burnstein KL.
    Endocr Relat Cancer; 2011 Apr 12; 18(2):207-19. PubMed ID: 21118977
    [Abstract] [Full Text] [Related]

  • 33. Structural requirements for PAK activation by Rac GTPases.
    Knaus UG, Wang Y, Reilly AM, Warnock D, Jackson JH.
    J Biol Chem; 1998 Aug 21; 273(34):21512-8. PubMed ID: 9705280
    [Abstract] [Full Text] [Related]

  • 34. Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation.
    Royal I, Lamarche-Vane N, Lamorte L, Kaibuchi K, Park M.
    Mol Biol Cell; 2000 May 21; 11(5):1709-25. PubMed ID: 10793146
    [Abstract] [Full Text] [Related]

  • 35. The role of Rho GTPases' substrates Rac and Cdc42 in osteoclastogenesis and relevant natural medicinal products study.
    Liu Y, Dou Y, Yan L, Yang X, He B, Kong L, Smith W.
    Biosci Rep; 2020 Jul 31; 40(7):. PubMed ID: 32578854
    [Abstract] [Full Text] [Related]

  • 36. A Novel Bioengineered miR-127 Prodrug Suppresses the Growth and Metastatic Potential of Triple-Negative Breast Cancer Cells.
    Umeh-Garcia M, Simion C, Ho PY, Batra N, Berg AL, Carraway KL, Yu A, Sweeney C.
    Cancer Res; 2020 Feb 01; 80(3):418-429. PubMed ID: 31694904
    [Abstract] [Full Text] [Related]

  • 37. Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
    Zhu A, Li Y, Song W, Xu Y, Yang F, Zhang W, Yin Y, Guan X.
    Cell Physiol Biochem; 2016 Feb 01; 38(3):1003-14. PubMed ID: 26938985
    [Abstract] [Full Text] [Related]

  • 38. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
    Charan M, Das S, Mishra S, Chatterjee N, Varikuti S, Kaul K, Misri S, Ahirwar DK, Satoskar AR, Ganju RK.
    Cell Death Dis; 2020 Sep 17; 11(9):774. PubMed ID: 32943608
    [Abstract] [Full Text] [Related]

  • 39. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
    Wu C, Qiu S, Liu P, Ge Y, Gao X.
    J Ethnopharmacol; 2018 Jan 30; 211():89-100. PubMed ID: 28962890
    [Abstract] [Full Text] [Related]

  • 40. An essential role for Rac/Cdc42 GTPases in cerebellar granule neuron survival.
    Linseman DA, Laessig T, Meintzer MK, McClure M, Barth H, Aktories K, Heidenreich KA.
    J Biol Chem; 2001 Oct 19; 276(42):39123-31. PubMed ID: 11509562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.